Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  carboxyamidotriazole
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-10 of 10 for your search:
Start Over
Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02898, CDR0000067033, 97-24-51, NCCTG-97-24-51, U10CA025224, NCT00003869
Phase I/II Study of Daily Oral Carboxyaminoimidazole (CAI) for Refractory Solid Tumors or Lymphoma (Summary Last Modified 11/2000)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 or over
Sponsor: NCI
Protocol IDs: WCCC-CO-9397, NCI-T93-0193C, T93-0193
Phase II Study of Oral Carboxyamidotriazole in Patients with Androgren-Independent Prostate Cancer (Summary Last Modified 09/98)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-97-C-0059C, NCI-T96-0053, T96-0053
Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000066216, NCI-98-C-0012, NCI-T97-0112, T97-0112, NCT00019461
Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03011, CDR67378, NABTT-9904, U01CA062475, JHOC-NABTT-9904, NCT00004146
Phase II Study of Carboxyamidotriazole in Patients With Advanced Renal Cell Cancer Refractory to Immunotherapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-4896, NCT00005045, E4896
Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02364, CLB-69901, U10CA031946, CDR0000068317, CALGB-69901, NCT00006486
Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02265, UCCRC-9019, NCI-T97-0086, CDR0000066129, T97-0086, NCT00003249
Phase I Study of Carboxyamidotriazole for Refractory Cancers (Summary Last Modified 12/98)
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: NCI-92-C-0054P, NCI-MB-281, NCI-T91-0170N, T91-0170
Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, NIH WGMCC
Protocol IDs: 950015, 95-C-0015, NCI-CPB-334, NCI-T94-0006N, CDR0000063881, NCI-95-C-0015, T94-0006, NCT00019019
Start Over